Live Chat Software
- Examine the intersections between hub-provided prior authorization support, coverage investigations, and copay support
- Design a patient service solution that helps patients’ access financial assistance programs and copay support
- Leverage hubs to complete benefits investigations, review formulary requirements, explore copay assistance offerings, and identify prior authorizations or step therapy requirements
- Discuss emerging hub models
- Understand how to do an analysis of risk exposure for copay programs dependent on the product profile
- Examine the evolving regulatory landscape and gross-to-net changes to ensure product effectiveness and a thorough risk mitigation strategy
- Design an internal risk detection strategy to safeguard against risk factors
- Understand how copays and rebates impact on drug pricing strategies and patient out-of-pocket costs
- Unpack the latest proposals, recommendations, and regulations around pricing and affordability of drugs
- Gain insight in the role copays play in current drug pricing conversations
Rob Philo
|
|
Rob Philo
Vice President, Market Access Veloxis Pharmaceuticals |
- Explore strategies used by the advocacy function to increase education, engagement, and awareness of patient groups when developing new therapies
- Understand the needs of the patient community, going beyond the pill, to ensure access to quality health care and personal needs
- Share successes to overcome barriers to patient access and affordability
- Evaluate the importance of medicines in achieving the Triple Aim goals
- Identify barriers to adherence and evaluate successful interventions that can be achieved by different stakeholder groups
- Analyze points for stakeholder collaboration around adherence initiatives that impact cost, quality, and outcomes
- Assess the patient journey and the opportunities to influence patient behavior across the continuum of care
Rodrigo Cerda
|
|
Rodrigo Cerda
Vice President, Clinical Care Transformation Independence Blue Cross |
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey
Steven Peskin
|
|
Steven Peskin, MD, MBA, FACP
Executive Medical Director, Population Health Horizon Blue Cross Blue Shield of New Jersey |
Steven R. Peskin, MD is the Executive Medical Director, Population Health at Horizon Blue Cross Blue Shield of New Jersey. His expertise encompasses physician leadership, population health management, clinical and operational performance improvement in health care, medical education and scientific communications. He has been one of the driving forces for the creation of and successful maturation of value based models in New Jersey.
Dr. Peskin is an Associate Clinical Professor in the Department of Medicine at Rutgers Robert Wood Johnson Medical School. He is a clinical preceptor at The Eric B, Chandler Clinic for interns and residents in Internal Medicine. Dr. Peskin assists with the Population Health and business of medicine training for the Rutgers RWJ Internal Medicine physicians in training.
Dr. Peskin received his bachelor’s degree from The University of North Carolina Chapel Hill and medical degree from Emory University School of Medicine. He completed residency at Saint Elizabeth’s Medical Center in Boston and holds an MBA from the Sloan School of Management at Massachusetts Institute of Technology.